Literature DB >> 19564549

Growth arrest specific protein 6 participates in DOCA-induced target-organ damage.

Joon-Keun Park1, Stefanie Theuer, Torsten Kirsch, Carsten Lindschau, Uwe Klinge, Arnd Heuser, Ralph Plehm, Mihai Todiras, Peter Carmeliet, Hermann Haller, Friedrich C Luft, Dominik N Muller, Anette Fiebeler.   

Abstract

Growth arrest-specific protein 6 (Gas 6) is involved in inflammatory kidney diseases, vascular remodeling, cell adhesion, and thrombus formation. We explored a role for Gas 6 in aldosterone-induced target organ damage. We observed that Gas 6 was upregulated in rats with high aldosterone levels. Mineralocorticoid receptor blockade prevented target organ damage and decreased the elevated Gas 6 expression. Vascular smooth muscle cells given aldosterone increased their Gas 6 expression in vitro. To test the pathophysiological relevance, we investigated the effects of deoxycorticosterone acetate (DOCA) on Gas 6 gene-deleted ((-/-)) mice. After 6 weeks DOCA, Gas 6(-/-) mice developed similar telemetric blood pressure elevations compared to wild-type mice but were protected from cardiac hypertrophy. Cardiac expression of interleukin 6 and collagen IV was blunted in Gas 6(-/-) mice, indicating reduced inflammation and fibrosis. Gas 6(-/-) mice also had an improved renal function with reduced albuminuria, compared to wild-type mice. Renal fibrosis and fibronectin deposition in the kidney were also reduced. Gas 6 deficiency reduces the detrimental effects of aldosterone on cardiac and renal remodeling independent of blood pressure reduction. Gas 6 appears to play a role in mineralocorticoid receptor-mediated target organ damage. Furthermore, because warfarin interferes with Gas 6 protein expression, the findings could be of clinical relevance for anticoagulant choices.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564549     DOI: 10.1161/HYPERTENSIONAHA.109.129460

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Innate Immune Cells Are Regulated by Axl in Hypertensive Kidney.

Authors:  Sri N Batchu; George J Dugbartey; Kristine M Wadosky; Deanne M Mickelsen; Kyung A Ko; Ronald W Wood; Yuqi Zhao; Xia Yang; Deborah J Fowell; Vyacheslav A Korshunov
Journal:  Am J Pathol       Date:  2018-08       Impact factor: 4.307

3.  Role of Axl in early kidney inflammation and progression of salt-dependent hypertension.

Authors:  Sri N Batchu; Angie Hughson; Janice Gerloff; Deborah J Fowell; Vyacheslav A Korshunov
Journal:  Hypertension       Date:  2013-06-17       Impact factor: 10.190

4.  Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.

Authors:  N Batchu; Vyacheslav A Korshunov; Angie Hughson; Kristine M Wadosky; Craig N Morrell; Deborah J Fowell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-06-30       Impact factor: 8.311

5.  Postmortem serum protein growth arrest-specific 6 levels in sepsis-related deaths.

Authors:  Cristian Palmiere; Marc Augsburger
Journal:  Int J Legal Med       Date:  2015-08-02       Impact factor: 2.686

6.  Role of emerging vitamin K‑dependent proteins: Growth arrest‑specific protein 6, Gla‑rich protein and periostin (Review).

Authors:  Huiyu Xiao; Jiepeng Chen; Lili Duan; Shuzhuang Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

7.  Vaccarin alleviates hypertension and nephropathy in renovascular hypertensive rats.

Authors:  Weiwei Cai; Zhenpeng Zhang; Yiqi Huang; Haijian Sun; Liying Qiu
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

Review 8.  Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review).

Authors:  Lianpu Wen; Jiepeng Chen; Lili Duan; Shuzhuang Li
Journal:  Mol Med Rep       Date:  2018-04-27       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.